Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation

被引:56
作者
Aylon, Y. [1 ]
Yabuta, N. [2 ]
Besserglick, H. [1 ]
Buganim, Y. [1 ]
Rotter, V. [1 ]
Nojima, H. [2 ]
Oren, M. [1 ]
机构
[1] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel
[2] Osaka Univ, Microbial Dis Res Inst, Dept Mol Genet, Osaka, Japan
关键词
Ras; p53; Lats2; apoptosis; MAMMARY EPITHELIAL-CELLS; DOWN-REGULATION; PROMOTER HYPERMETHYLATION; DNA HYPERMETHYLATION; GENOMIC INSTABILITY; INDUCED SENESCENCE; P53; P16(INK4A); MUTATIONS; CANCER;
D O I
10.1038/onc.2009.270
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Lats2 tumor suppressor protein has been implicated earlier in promoting p53 activation in response to mitotic apparatus stress, by preventing Mdm2-driven p53 degradation. We now report that Lats2 also has a role in an ATR-Chk1-mediated stress check point in response to oncogenic H-Ras. Activated mutant H-Ras triggers the translocation of Lats2 from centrosomes into the nucleus, coupled with an increase in Lats2 protein levels. This leads to the induction of p53 activity, upregulation of proapoptotic genes, downregulation of antiapoptotic genes and eventually apoptotic cell death. Many of the cells that survive apoptosis undergo senescence. However, a fraction of the cells escape this checkpoint mechanism, despite maintaining a high mutant H-Ras expression. These escapers display increased genome instability, as evidenced by a substantial fraction of cells with micronuclei and cells with polyploid genomes. Interestingly, such cells show markedly reduced levels of Lats2, in conjunction with enhanced hypermethylation of the Lats2 gene promoter. Our findings suggest that Lats2 might have an important role in quenching H-Ras-induced transformation, whereas silencing of Lats2 expression might serve as a mechanism to enable tumor progression. Oncogene (2009) 28, 4469-4479; doi:10.1038/onc.2009.270; published online 26 October 2009
引用
收藏
页码:4469 / 4479
页数:11
相关论文
共 36 条
  • [1] Ras induces chromosome instability and abrogation of the DNA damage response
    Abulaiti, Adili
    Fikaris, Aphrothiti J.
    Tsygankova, Oxana M.
    Meinkoth, Judy L.
    [J]. CANCER RESEARCH, 2006, 66 (21) : 10505 - 10512
  • [2] A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization
    Aylon, Yael
    Michael, Dan
    Shmueli, Ayelet
    Yabuta, Norikazu
    Nojima, Hiroshi
    Oren, Moshe
    [J]. GENES & DEVELOPMENT, 2006, 20 (19) : 2687 - 2700
  • [3] DNA damage signalling guards against activated oncogenes and tumour progression
    Bartek, J.
    Bartkova, J.
    Lukas, J.
    [J]. ONCOGENE, 2007, 26 (56) : 7773 - 7779
  • [4] Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
    Bartkova, Jirina
    Rezaei, Nousin
    Liontos, Michalis
    Karakaidos, Panagiotis
    Kletsas, Dimitris
    Issaeva, Natalia
    Vassiliou, Leandros-Vassilios F.
    Kolettas, Evangelos
    Niforou, Katerina
    Zoumpourlis, Vassilis C.
    Takaoka, Munenori
    Nakagawa, Hiroshi
    Tort, Frederic
    Fugger, Kasper
    Johansson, Fredrik
    Sehested, Maxwell
    Andersen, Claus L.
    Dyrskjot, Lars
    Orntoft, Torben
    Lukas, Jiri
    Kittas, Christos
    Helleday, Thomas
    Halazonetis, Thanos D.
    Bartek, Jiri
    Gorgoulis, Vassilis G.
    [J]. NATURE, 2006, 444 (7119) : 633 - 637
  • [5] Morphologically normal-appearing mammary epithelial cells obtained from high-risk women exhibit methylation silencing of INK4a/ARF
    Bean, Gregory R.
    Bryson, Andrew D.
    Pilie, Patrick G.
    Goldenberg, Vanessa
    Baker, Joseph C., Jr.
    Ibarra, Catherine
    Brander, Danielle M. U.
    Paisie, Carolyn
    Case, Natalie R.
    Gauthier, Mona
    Reynolds, Paul A.
    Dietze, Eric
    Ostrander, Julie
    Scott, Victoria
    Wilke, Lee G.
    Yee, Lisa
    Kimler, Bruce F.
    Fabian, Carol J.
    Zalles, Carola M.
    Broadwater, Gloria
    Tisty, Thea D.
    Seewaldt, Victoria L.
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (22) : 6834 - 6841
  • [6] Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer
    Burri, N
    Shaw, P
    Bouzourene, H
    Sordat, I
    Sordat, B
    Gillet, M
    Schorderet, D
    Bosman, FT
    Chaubert, P
    [J]. LABORATORY INVESTIGATION, 2001, 81 (02) : 217 - 229
  • [7] Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation
    Chang, Hui-Chiu
    Cho, Chun-Yu
    Hung, Wen-Chun
    [J]. CANCER RESEARCH, 2006, 66 (17) : 8413 - 8420
  • [8] MITOTIC AND POST MITOTIC CONSEQUENCES OF GENOMIC INSTABILITY INDUCED BY ONCOGENIC HA-RAS
    DENKO, N
    STRINGER, J
    WANI, M
    STAMBROOK, P
    [J]. SOMATIC CELL AND MOLECULAR GENETICS, 1995, 21 (04) : 241 - 253
  • [9] Somatic mutations affect key pathways in lung adenocarcinoma
    Ding, Li
    Getz, Gad
    Wheeler, David A.
    Mardis, Elaine R.
    McLellan, Michael D.
    Cibulskis, Kristian
    Sougnez, Carrie
    Greulich, Heidi
    Muzny, Donna M.
    Morgan, Margaret B.
    Fulton, Lucinda
    Fulton, Robert S.
    Zhang, Qunyuan
    Wendl, Michael C.
    Lawrence, Michael S.
    Larson, David E.
    Chen, Ken
    Dooling, David J.
    Sabo, Aniko
    Hawes, Alicia C.
    Shen, Hua
    Jhangiani, Shalini N.
    Lewis, Lora R.
    Hall, Otis
    Zhu, Yiming
    Mathew, Tittu
    Ren, Yanru
    Yao, Jiqiang
    Scherer, Steven E.
    Clerc, Kerstin
    Metcalf, Ginger A.
    Ng, Brian
    Milosavljevic, Aleksandar
    Gonzalez-Garay, Manuel L.
    Osborne, John R.
    Meyer, Rick
    Shi, Xiaoqi
    Tang, Yuzhu
    Koboldt, Daniel C.
    Lin, Ling
    Abbott, Rachel
    Miner, Tracie L.
    Pohl, Craig
    Fewell, Ginger
    Haipek, Carrie
    Schmidt, Heather
    Dunford-Shore, Brian H.
    Kraja, Aldi
    Crosby, Seth D.
    Sawyer, Christopher S.
    [J]. NATURE, 2008, 455 (7216) : 1069 - 1075
  • [10] Molecular origins of cancer: Epigenetics in cancer
    Esteller, Manel
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (11) : 1148 - 1159